Two‐decade battle with myasthenia gravis: A breakthrough case report on the long‐term success with eculizumab and ravulizumab treatment
Key Clinical Message This unique case of generalized myasthenia gravis shows sustained stability of a patient's condition for 3 years with eculizumab/ravulizumab treatment following 16 years of refractory disease. It highlights the long‐term effectiveness of C5 inhibitors in a real‐world settin...
| Published in: | Clinical Case Reports |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.9547 |